These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

154 related items for PubMed ID: 2161885

  • 21. Structure and function of the complement receptors, CR1 (CD35) and CR2 (CD21).
    Ahearn JM, Fearon DT.
    Adv Immunol; 1989; 46():183-219. PubMed ID: 2551147
    [No Abstract] [Full Text] [Related]

  • 22. Mapping of the C3d receptor (CR2)-binding site and a neoantigenic site in the C3d domain of the third component of complement.
    Lambris JD, Ganu VS, Hirani S, Müller-Eberhard HJ.
    Proc Natl Acad Sci U S A; 1985 Jun; 82(12):4235-9. PubMed ID: 2408276
    [Abstract] [Full Text] [Related]

  • 23. The Structure-Function Relationships of Complement Receptor Type 2 (CR2; CD21).
    Hannan JP.
    Curr Protein Pept Sci; 2016 Jun; 17(5):463-87. PubMed ID: 26916158
    [Abstract] [Full Text] [Related]

  • 24. Cell cycle control of a Burkitt lymphoma cell line: responsiveness to growth signals engaging the C3D/EBV receptor.
    Pernegger G, Schulz TF, Hosp M, Myones BL, Petzer AL, Eigentler A, Böck G, Wick G, Dierich MP.
    Immunology; 1988 Oct; 65(2):237-41. PubMed ID: 2461345
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Analysis of epitope expression and the functional repertoire of recombinant complement receptor 2 (CR2/CD21) in mouse and human cells.
    Carel JC, Frazier B, Ley TJ, Holers VM.
    J Immunol; 1989 Aug 01; 143(3):923-30. PubMed ID: 2473114
    [Abstract] [Full Text] [Related]

  • 27. Incorporation of the purified Epstein Barr virus/C3d receptor (CR2) into liposomes and demonstration of its dual ligand binding functions.
    Mold C, Cooper NR, Nemerow GR.
    J Immunol; 1986 Jun 01; 136(11):4140-5. PubMed ID: 3009615
    [Abstract] [Full Text] [Related]

  • 28. Intersection of the complement and immune systems: a signal transduction complex of the B lymphocyte-containing complement receptor type 2 and CD19.
    Matsumoto AK, Kopicky-Burd J, Carter RH, Tuveson DA, Tedder TF, Fearon DT.
    J Exp Med; 1991 Jan 01; 173(1):55-64. PubMed ID: 1702139
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Binding of C3 and C3dg to the CR2 complement receptor induces growth of an Epstein-Barr virus-positive human B cell line.
    Hatzfeld A, Fischer E, Levesque JP, Perrin R, Hatzfeld J, Kazatchkine MD.
    J Immunol; 1988 Jan 01; 140(1):170-5. PubMed ID: 2826586
    [Abstract] [Full Text] [Related]

  • 31. Identification and characterization of the Epstein-Barr virus receptor on human B lymphocytes and its relationship to the C3d complement receptor (CR2).
    Nemerow GR, Wolfert R, McNaughton ME, Cooper NR.
    J Virol; 1985 Aug 01; 55(2):347-51. PubMed ID: 2410629
    [Abstract] [Full Text] [Related]

  • 32. Epstein-Barr virus gp350/220 binding to the B lymphocyte C3d receptor mediates adsorption, capping, and endocytosis.
    Tanner J, Weis J, Fearon D, Whang Y, Kieff E.
    Cell; 1987 Jul 17; 50(2):203-13. PubMed ID: 3036369
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Interaction of iC3b with recombinant isotypic and chimeric forms of CR2.
    Kalli KR, Ahearn JM, Fearon DT.
    J Immunol; 1991 Jul 15; 147(2):590-4. PubMed ID: 1830068
    [Abstract] [Full Text] [Related]

  • 38. Deficiencies of human C3 complement receptors type 1 (CR1, CD35) and type 2 (CR2, CD21).
    Kazatchkine MD, Fearon DT.
    Immunodefic Rev; 1990 Jul 15; 2(1):17-41. PubMed ID: 2164822
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Complement receptor type two (CR2,CR21): a target for influencing the humoral immune response and antigen-trapping.
    Prodinger WM.
    Immunol Res; 1999 Jul 15; 20(3):187-94. PubMed ID: 10741859
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.